Evidence map›Paper›PMID 21373790›Full record

Trial reportPsychopharmacology2011

Aripiprazole maintenance increases smoked cocaine self-administration in humans.

Margaret Haney, Eric Rubin, Richard W Foltin

Abstract readClinical Trial
In one paragraph

Trial report in Psychopharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Antipsychotic medications for cocaine dependence.The Cochrane database of systematic reviews · 2016
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. The Persistent Challenge of Developing Addiction Pharmacotherapies.Cold Spring Harbor perspectives in medicine · 2021
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Margaret HaneyDepartment of Psychiatry, College of Physicians and Surgeons of Columbia University and Division on Substance Abuse, New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA. mh235@columbia.edu
Eric Rubin
Richard W Foltin
New York State Psychiatric Institute

Funding

ZOLEDRONIC ACID IN PROSTATE CANCERM01RR000645 · NCRR · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI COLTEN, HARVEY R · 1985 to 2006
$27.0M
IV COCAINE ABUSE TREATMENT: A LABORATORY MODELR01DA006234 · NIDA · JOHNS HOPKINS UNIVERSITY · PI FOLTIN, RICHARD W · 1990 to 2007
$4.1M
NOVEL COCAINE PHARMACOTHERAPIES: LAB STUDIESR01DA010755 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HANEY, MARGARET · 1996 to 2003
$2.1M
NCRR NIH HHS M01 RR000645NCRR NIH HHS MOI-RR-00645NIDA NIH HHS DA006234NIDA NIH HHS DA10755/NIDA NIH HHS R01 DA006234NIDA NIH HHS R01 DA010755
6 · The paper itself

Abstract

rationalePartial dopamine receptor agonists have been proposed as candidate pharmacotherapies for cocaine dependence.

objectiveThis 42-day, within-subject, human laboratory study assessed how maintenance on aripiprazole, a partial D(2) receptor agonist, influenced smoked cocaine self-administration, cardiovascular measures, subjective effects, and cocaine craving in nontreatment-seeking, cocaine-dependent volunteers.

methodsIn order to achieve steady-state concentrations, participants (n = 8 men) were administered placebo and aripiprazole (15 mg/day) capsules in counter-balanced order for 21 days. A smoked cocaine dose-response curve (0, 12, 25, 50 mg) was determined twice under placebo and aripiprazole maintenance. Sessions comprised a "sample" trial, when participants smoked the cocaine dose available that session, and five choice trials, when they responded on a progressive-ratio schedule of reinforcement to receive the cocaine dose or receive $5.00.

resultsCocaine's reinforcing, subjective, and cardiovascular effects were dose-dependent. Aripiprazole significantly increased cocaine (12, 25 mg) self-administration. Following a single administration of cocaine (25 mg), aripiprazole decreased ratings of how much participants would pay for that dose. Following repeated cocaine (50 mg) self-administration, aripiprazole decreased ratings of cocaine quality, craving, and good drug effect as compared to placebo.

conclusionsThese data suggest that aripiprazole may have increased self-administration to compensate for a blunted subjective cocaine effect. Overall, the findings do not suggest aripiprazole would be useful for treating cocaine dependence.

Indexed as

AdultAripiprazoleBlood PressureCocaineCocaine-Related DisordersDopamine AgonistsDose-Response Relationship, DrugElectrocardiographyHeart RateHumansMalePiperazinesQuinolonesReinforcement ScheduleSelf AdministrationSmokeAripiprazoleCocaineDopamine AgonistsPiperazinesQuinolonesSmoke

Identifiers

PMID21373790
PMCPMC3133869
OpenAlexW2006821655

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.